The present invention relates to a nanoparticulate formulation comprising a microsomal prostaglandin E synthases 1 (mPGES 1) inhibitor. Particularly the present invention relates to a nanoparticulate formulation comprising an mPGES 1 inhibitor and one or more surface stabilizers a process for preparing such formulation and its use in treating pain and inflammation in a subject.